Tvardi Therapeutics, Inc. (TVRD)
1.80
-0.02
(-1.10%)
USD |
NASDAQ |
Aug 31, 16:00
1.83
+0.03
(+1.67%)
After-Hours: 20:00
Tvardi Therapeutics Price to Book Value : 2.015 for Aug. 31, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 31, 2026 | 2.015 |
| August 28, 2026 | 2.037 |
| August 27, 2026 | 2.015 |
| August 26, 2026 | 1.992 |
| August 25, 2026 | 2.037 |
| August 24, 2026 | 1.992 |
| August 21, 2026 | 2.082 |
| August 20, 2026 | 2.048 |
| August 19, 2026 | 2.104 |
| August 18, 2026 | 2.126 |
| August 17, 2026 | 2.082 |
| August 14, 2026 | 2.126 |
| August 13, 2026 | 1.981 |
| August 12, 2026 | 1.981 |
| August 11, 2026 | 1.981 |
| August 10, 2026 | 1.970 |
| August 07, 2026 | 2.093 |
| August 06, 2026 | 2.071 |
| August 05, 2026 | 2.238 |
| August 04, 2026 | 2.272 |
| August 03, 2026 | 2.261 |
| July 31, 2026 | 2.350 |
| July 30, 2026 | 2.350 |
| July 29, 2026 | 2.395 |
| July 28, 2026 | 2.731 |
| Date | Value |
|---|---|
| July 27, 2026 | 2.843 |
| July 24, 2026 | 2.809 |
| July 23, 2026 | 2.865 |
| July 22, 2026 | 3.089 |
| July 21, 2026 | 3.201 |
| July 20, 2026 | 3.279 |
| July 17, 2026 | 3.582 |
| July 16, 2026 | 3.447 |
| July 15, 2026 | 3.279 |
| July 14, 2026 | 3.470 |
| July 13, 2026 | 3.705 |
| July 10, 2026 | 3.671 |
| July 09, 2026 | 4.253 |
| July 08, 2026 | 5.596 |
| July 07, 2026 | 3.470 |
| July 06, 2026 | 2.250 |
| July 02, 2026 | 2.261 |
| July 01, 2026 | 2.182 |
| June 30, 2026 | 2.126 |
| June 29, 2026 | 1.235 |
| June 26, 2026 | 0.9701 |
| June 25, 2026 | 1.526 |
| June 24, 2026 | 1.520 |
| June 23, 2026 | 1.565 |
| June 22, 2026 | 1.733 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.15 |
| Crinetics Pharmaceuticals, Inc. | 7.541 |
| Liquidia Corp. | 31.13 |
| ANI Pharmaceuticals, Inc. | 2.818 |
| Corcept Therapeutics, Inc. | 17.33 |
Price to Book Value Related Metrics
| Price | 1.80 |
| Earnings Yield | -154.4% |
| Market Cap | 16.89M |